DE602005026072D1 - Ligand für den formylpeptidrezeptorähnlichen-2 (FPRL2) G Protein gekoppelten Rezeptor - Google Patents

Ligand für den formylpeptidrezeptorähnlichen-2 (FPRL2) G Protein gekoppelten Rezeptor

Info

Publication number
DE602005026072D1
DE602005026072D1 DE602005026072T DE602005026072T DE602005026072D1 DE 602005026072 D1 DE602005026072 D1 DE 602005026072D1 DE 602005026072 T DE602005026072 T DE 602005026072T DE 602005026072 T DE602005026072 T DE 602005026072T DE 602005026072 D1 DE602005026072 D1 DE 602005026072D1
Authority
DE
Germany
Prior art keywords
receptor
protein
fprl2
ligand
formyl peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005026072T
Other languages
English (en)
Inventor
Isabelle Migeotte
Marc Parmentier
David Communi
Maryse Brait
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ogeda SA
Original Assignee
Euroscreen SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euroscreen SA filed Critical Euroscreen SA
Publication of DE602005026072D1 publication Critical patent/DE602005026072D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE602005026072T 2004-05-14 2005-05-13 Ligand für den formylpeptidrezeptorähnlichen-2 (FPRL2) G Protein gekoppelten Rezeptor Active DE602005026072D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04447122 2004-05-14
EP04447231 2004-10-18

Publications (1)

Publication Number Publication Date
DE602005026072D1 true DE602005026072D1 (de) 2011-03-03

Family

ID=34982585

Family Applications (2)

Application Number Title Priority Date Filing Date
DE602005026072T Active DE602005026072D1 (de) 2004-05-14 2005-05-13 Ligand für den formylpeptidrezeptorähnlichen-2 (FPRL2) G Protein gekoppelten Rezeptor
DE602005019495T Active DE602005019495D1 (de) 2004-05-14 2005-05-13 Ligand für den Formylpeptidrezeptorähnlichen- 2 (FPRL2) G Protein gekoppelten Rezeptor und dessen Anwendung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE602005019495T Active DE602005019495D1 (de) 2004-05-14 2005-05-13 Ligand für den Formylpeptidrezeptorähnlichen- 2 (FPRL2) G Protein gekoppelten Rezeptor und dessen Anwendung

Country Status (7)

Country Link
US (3) US7582416B2 (de)
EP (2) EP2020604B1 (de)
JP (2) JP4694887B2 (de)
AT (2) ATE459004T1 (de)
CA (2) CA2504920C (de)
DE (2) DE602005026072D1 (de)
DK (2) DK2020604T3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495662B1 (en) * 1998-10-22 2002-12-17 The General Hospital Corporation Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
WO2001023521A2 (en) * 1999-09-29 2001-04-05 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
US7572765B2 (en) * 2001-07-23 2009-08-11 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
AU2003220380A1 (en) * 2003-03-19 2004-11-19 Bristol-Myers Squibb Company CONFORMATIONALLY CONSTRAINED PARATHYROID HORMONES WITH Alpha-HELIX STABILIZERS
EP1653985A4 (de) 2003-07-17 2009-08-05 Gen Hospital Corp Zwangsform-parathormon (pth)-analoga
CA2504920C (en) * 2004-05-14 2014-04-01 Euroscreen S.A. Ligand for g-protein coupled receptor fprl2 and uses thereof
US8143374B2 (en) * 2006-08-04 2012-03-27 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (PTH)
US20090004755A1 (en) * 2007-03-23 2009-01-01 Biosite, Incorporated Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
US8221995B2 (en) 2007-03-23 2012-07-17 Seok-Won Lee Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
PE20090321A1 (es) 2007-06-04 2009-04-20 Genentech Inc Anticuerpos anti-notch1 nrr, metodo de preparacion y composicion farmaceutica
WO2008156858A2 (en) * 2007-06-20 2008-12-24 University Of Utah Research Foundation Use of pre-mrna splicing in platelet cells for the diagnosis of disease
AU2008282805B2 (en) * 2007-08-01 2014-05-01 Chugai Pharmaceutical Co., Ltd. Screening methods using G-protein coupled receptors and related compositions
WO2010063652A1 (en) * 2008-12-04 2010-06-10 Sanofi-Aventis Methods and uses involving heme binding protein 1
US8563714B2 (en) 2009-05-18 2013-10-22 Actelion Pharmaceuticals Ltd. Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists
WO2011073918A2 (en) 2009-12-16 2011-06-23 Actelion Pharmaceuticals Ltd Peptides as modulators of fprl1 and/or fprl2
CN103002906B (zh) 2010-05-13 2017-12-29 总医院有限公司 甲状旁腺激素类似物及其应用
JP6782716B2 (ja) * 2015-06-25 2020-11-11 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 抗体またはリガンドの結合および機能を明らかにするための細胞ベースアッセイ法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005745A1 (en) 1988-11-18 1990-05-31 The General Hospital Corporation A cAMP-RESPONSIVE TRANSCRIPTIONAL ENHANCER BINDING PROTEIN
DE69229477T2 (de) 1991-09-23 1999-12-09 Cambridge Antibody Tech Methoden zur Herstellung humanisierter Antikörper
CA2115811A1 (en) 1993-02-17 1994-08-18 Claus Krebber A method for in vivo selection of ligand-binding proteins
ATE219517T1 (de) 1995-08-18 2002-07-15 Morphosys Ag Protein-/(poly)peptidbibliotheken
US7119190B2 (en) * 1997-04-14 2006-10-10 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human G protein-coupled receptors
ES2192060T5 (es) 1998-07-06 2009-05-01 Perkinelmer Cellular Sciences Belgium Bvba Ensayo de bioluminiscencia para agonistas o antagonistas de un receptor acoplado al calcio.
AU7494200A (en) * 1999-09-15 2001-04-17 Incyte Genomics, Inc. Proteins associated with cell differentiation
US6436703B1 (en) 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
JP4184875B2 (ja) * 2002-06-14 2008-11-19 武田薬品工業株式会社 新規スクリーニング方法
CA2504920C (en) * 2004-05-14 2014-04-01 Euroscreen S.A. Ligand for g-protein coupled receptor fprl2 and uses thereof

Also Published As

Publication number Publication date
EP2020604B1 (de) 2011-01-19
EP1607745B1 (de) 2010-02-24
EP2020604A1 (de) 2009-02-04
US20100009406A1 (en) 2010-01-14
EP1607745A2 (de) 2005-12-21
US20090053739A1 (en) 2009-02-26
US20060078559A1 (en) 2006-04-13
JP2006025787A (ja) 2006-02-02
US7659251B2 (en) 2010-02-09
ATE459004T1 (de) 2010-03-15
CA2504920A1 (en) 2005-11-14
CA2504920C (en) 2014-04-01
DE602005019495D1 (de) 2010-04-08
JP4694887B2 (ja) 2011-06-08
JP2011078437A (ja) 2011-04-21
CA2810292C (en) 2015-09-29
DK2020604T3 (da) 2011-05-16
EP1607745A3 (de) 2006-07-26
US7842795B2 (en) 2010-11-30
DK1607745T3 (da) 2010-06-14
US7582416B2 (en) 2009-09-01
JP5314061B2 (ja) 2013-10-16
CA2810292A1 (en) 2005-11-14
ATE496304T1 (de) 2011-02-15

Similar Documents

Publication Publication Date Title
DE602005026072D1 (de) Ligand für den formylpeptidrezeptorähnlichen-2 (FPRL2) G Protein gekoppelten Rezeptor
HK1211618A1 (en) Nogo receptor binding protein nogo
HK1142272A1 (en) Specific binding proteins and uses thereof
ATE504599T1 (de) Zur aktivierung von rezeptoren fähige fusionspolypeptide
WO2006113602A3 (en) Ascorbate binding peptides
WO2005087811A3 (en) Estrogen receptors and methods of use
WO2007136778A3 (en) Fusion proteins, uses thereof and processes for producing same
WO2005063816A3 (en) Monovalent antibody fragments useful as therapeutics
WO2005051998A3 (en) Antibodies binding to a c-terminal fragment of apolipoprotein e
DK1430133T3 (da) En oplöselig Toll-lignende receptor
WO2003001863A3 (en) Novel endothelially expressed dnas and proteins, and their use
EP1578953A4 (de) Verfahren zur bestimmung der primärstruktur der für die rekombinante menschliche endooligopeptidase a (heopa) codierenden boten-rna ¬af217798|...
RU2007142850A (ru) Пептид ded и его применение для идентификации и/или очистки рекомбинантных белков, вектор pded